Lightengale develops medical devices for improved ICU infusion lines.
Lightengale has raised $50K in total funding. The most recent round was Grant. The last funding was announced in February 2022.
Lightengale's investors include National Science Foundation, National Institutes of Health, Consortium For Technology & Innovation in Pediatrics.
Lightengale is headquartered in Decatur, United States.
Lightengale develops medical devices for improved ICU infusion lines.
Lightengale is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lightengale — Funding & Investors." VCBacked, February 8, 2022, https://www.vcbacked.co/company/lightengale. Accessed July 21, 2026.
VCBacked. (2022). Lightengale — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/lightengale
{{cite web |title=Lightengale — Funding & Investors |url=https://www.vcbacked.co/company/lightengale |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated